← Back to Clinical Trials
Recruiting NCT06593314
Using Ultromics EchoGo HFpEF Algorithm to Identify and Treat High Heart Failure Risk in Patients With Type 2 Diabetes
Trial Parameters
Condition Heart Failure
Sponsor University of Texas Southwestern Medical Center
Study Type INTERVENTIONAL
Phase N/A
Enrollment 800
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2025-08-06
Completion 2026-03-15
All Conditions
Interventions
Message with EchoGoStandard Message
Brief Summary
A pragmatic electronic health record (EHR) based randomized controlled trial to evaluate the utility of providing Ultromics EchoGo analysis results and recommendations for HF risk prevention therapies using an EHR embedded clinical decision support tool.
Eligibility Criteria
Clinical cohort inclusion exclusion criteria: Inclusion Criteria: * Patients with diagnosis of Type 2 diabetes and High WATCH DM score. * Echocardiogram available in last 6-months. Exclusion Criteria: * History of HF * Not eligible for prescription of new GLP-1RA or SGLT2i or ns-MRA Corresponding providers to patients identified by the above inclusion exclusion criteria will be included in the clinical trial of the decision support tool.
Related Trials
NCT06541509
Mechanisms of Semaglutide Therapy in Heart Failure Patients
View Trial →
NCT05596253
Incidence and Predictors of Post-TIPS Heart Failure in Patients With Cirrhosis
View Trial →
NCT07343895
Population-based Atrial Fibrillation Screening in Individuals With NT-proBNP Above Median in the Tro
View Trial →